The phosphoinositol-3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signalling pathway, which plays important biological roles in normal cellular physiology, has been demonstrated to be activated in breast cancer [3–4]. Here, AKT1 is linked to breast cancer.